CCT8

CCT8 is the theta subunit of the hetero-oligomeric cytosolic chaperonin CCT/TRiC complex, contributing ATPase-associated motifs shared across CCT subunits and assembling into the native heterooligomeric complex (PMID:7890169). Its expression is transcriptionally controlled by the ternary complex factors Elk-1, Sap-1a, and Net binding a promoter cis-element under Ras/MAPK control (PMID:12788937). Strikingly, ectopic CCT8 alone is sufficient to drive assembly of the full TRiC/CCT complex, and the resulting elevated chaperonin activity prevents aggregation of mutant Huntingtin and confers TRiC-dependent proteostatic protection (PMID:27892468). As a folding machine CCT8 chaperones specific clients, including TULP2 — which it engages through its apical domain and whose loss causes cytoplasmic aggregation and defective ciliogenesis (PMID:40613306) — while CCT8 itself depends on the FKBP4-Hsp90 co-chaperone system, linking the Hsp90 and chaperonin folding pathways and stabilizing downstream clients CDK2 and α-tubulin (PMID:41203126). Through this proteostatic role CCT8 supports cell cycle progression and cytoskeletal organization (PMID:24862099, PMID:26304164) and is required for thymocyte maturation, T cell activation, and protective immunity (PMID:34083746). In cancer, CCT8 acts in pro-tumorigenic signaling: it binds LASP1 to exclude wild-type p53 from the nucleus and promote EMT (PMID:34862361), interacts with and activates AKT to drive migration and metastasis (PMID:37928427), and functions downstream of GRP94 in a c-Jun/EMT cascade (PMID:26718209). CCT8 also serves as a host factor for influenza A replication via interaction with the viral PB2 protein (PMID:40135264).

1. 1995 Medium

   Established CCT8 as a bona fide subunit of the cytosolic chaperonin rather than a free-standing protein, defining its molecular identity.

   Evidence cDNA cloning, sequence motif analysis, and 2D gel analysis of the native CCT complex

   PMID:7890169

   Open questions at the time

   • ATPase activity inferred from motifs, not directly measured
   • subunit stoichiometry and arrangement within the complex not resolved
2. 2003 High

   Answered how CCT8 expression is controlled, linking chaperonin subunit levels to mitogenic Ras/MAPK signaling through specific TCF transcription factors.

   Evidence Reporter assays, EMSA, MAPK inhibitor, and dominant-negative TCF constructs on the promoter

   PMID:12788937

   Open questions at the time

   • downstream physiological consequences of TCF-driven CCT8 induction not tested
   • whether other CCT subunits are co-regulated unknown
3. 2016 High

   Demonstrated that CCT8 is rate-limiting for TRiC/CCT assembly and that boosting it has functional proteostatic consequences, reframing a single subunit as a lever on whole-complex activity.

   Evidence Ectopic CCT8 overexpression, native assembly assays, mutant Huntingtin aggregation readout, and TRiC-dependent C. elegans lifespan extension

   PMID:27892468

   Open questions at the time

   • structural basis for how excess CCT8 nucleates assembly not defined
   • client spectrum protected by elevated TRiC not enumerated
4. 2014 Medium

   Connected CCT8 loss to a defined cell-cycle phenotype, implicating chaperonin function in S-phase entry.

   Evidence siRNA knockdown with proliferation assays and flow cytometry in hepatocellular carcinoma cells

   PMID:24862099

   Open questions at the time

   • client(s) responsible for S-phase block not identified at this stage
   • single cell line
5. 2015 Medium

   Extended CCT8's cellular role to cytoskeletal organization and invasion, and positioned it within a GRP94-driven metastatic cascade.

   Evidence siRNA/shRNA knockdown, invasion and migration assays, cytoskeleton imaging, and western blot for c-Jun/EMT markers in glioblastoma and HCC cells

   PMID:26304164 PMID:26718209

   Open questions at the time

   • direct biochemical link between CCT8 and GRP94 not shown
   • molecular mechanism connecting CCT8 to c-Jun unresolved
6. 2021 Medium

   Identified specific physical partners (LASP1) and a signaling output, showing CCT8 controls p53 subcellular localization to drive EMT.

   Evidence Co-immunoprecipitation, nuclear fractionation/immunofluorescence for p53, functional assays, and clinical tissue correlation

   PMID:34862361

   Open questions at the time

   • mechanism by which the CCT8-LASP1 interaction excludes p53 not defined
   • whether p53 is a folding client unknown
7. 2021 High

   Established the physiological requirement for CCT chaperonin in adaptive immunity, linking proteostasis to T cell development, activation, and protective responses.

   Evidence Conditional CCT8 knockout in mice, proteomics, nuclear actin imaging, activation assays, and in vivo helminth infection

   PMID:34083746

   Open questions at the time

   • which T-cell client proteins are misfolded upon CCT loss not fully mapped
   • mechanism of aberrant Th2 polarization not resolved
8. 2023 Medium

   Placed CCT8 upstream of AKT in a pro-metastatic signaling axis, expanding its tumorigenic function beyond folding.

   Evidence Co-immunoprecipitation, overexpression/knockdown, AKT inhibitor rescue, and in vivo metastasis model in lung adenocarcinoma

   PMID:37928427

   Open questions at the time

   • whether AKT activation is direct or chaperone-mediated unclear
   • structural detail of CCT8-AKT interaction absent
9. 2025 Medium

   Defined a specific folding client (TULP2) engaged through the CCT8 apical domain, linking CCT8 to ciliogenesis and male fertility.

   Evidence Co-IP domain mapping, knockdown aggregation assay, IFT localization in KO mice, and a human TULP2 infertility variant

   PMID:40613306

   Open questions at the time

   • ATP-dependence of TULP2 folding cycle not shown
   • whole-complex vs CCT8-specific contribution to TULP2 folding unresolved
10. 2025 Medium

    Revealed crosstalk between Hsp90 and chaperonin systems by showing CCT8 itself is an FKBP4-Hsp90 client whose stability gates downstream clients.

    Evidence BioID proximity labeling, FKBP4 knockdown, CCT8 aggregation assay, and client stability blots (CDK2, α-tubulin)

    PMID:41203126

    Open questions at the time

    • whether FKBP4-Hsp90 acts on free CCT8 or assembled complex unknown
    • generality across CCT subunits untested
11. 2025 Medium

    Identified CCT8 as a host dependency factor for influenza A through interaction with viral PB2.

    Evidence Co-immunoprecipitation and knockdown/overexpression with viral titer readouts

    PMID:40135264

    Open questions at the time

    • whether PB2 is folded by CCT8 or merely bound unclear
    • single viral subtype tested
12. 2025 Low

    Proposed a CCT8-RPL4 interaction feeding into MDM2-p53 control of p53 degradation in colorectal cancer.

    Evidence Co-immunoprecipitation plus functional assays and bioinformatic network analysis

    PMID:40251552

    Open questions at the time

    • p53 ubiquitination/degradation mechanism inferred from correlation, not directly demonstrated
    • RPL4 interaction not reciprocally validated

• How CCT8-specific client selection and apical-domain recognition relate to whole-complex TRiC folding cycles, and how its many signaling outputs (AKT, p53, EMT) emerge mechanistically from chaperonin function, remain unresolved.
• no structural model of CCT8 client engagement within the assembled complex
• distinction between folding-dependent and folding-independent signaling roles not drawn
• comprehensive client repertoire undefined